Trials show GSK drug cures hepatitis B in nearly 20% of patients
GSK said on Thursday that late-stage trial results for its experimental drug for chronic hepatitis B, bepirovirsen, showed…
New hepatitis B drug from GSK wipes out all signs of the virus in some patients
WASHINGTON (AP) — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs…